658.9500 2.10 (0.32%)
NSE May 02, 2025 15:31 PM
Volume: 460.4K
 

ICICI Securities Limited
Krishna Institute of Medical Sciences’ (KIMS) Q3FY25 revenue was in-line while EBITDA and PAT were dragged by seasonality and its new Nashik hospitals. KIMS’ hospitals in Telangana/Andhra Pradesh grew a robust 26.1%/27.8% YoY. In Q3FY25, it commenced operations at its 325-bed hospital in Nashik (EBITDA loss of INR 50mn in Q3FY25), which is likely to break even by Q3FY26.
Number of FII/FPI investors increased from 206 to 226 in Mar 2025 qtr.
More from Krishna Institute of Medical Sciences Ltd.
Recommended